Podcast

Understanding Precision Medicine in Multiple Myeloma

Author(s):

Kristie L. Kahl

In this week’s episode of the “CURE Talks Cancer” podcast, we spoke with Dr. Cesar Rodriguez about precision medicine, and his recent trek to Patagonia with Moving Mountains for Multiple Myeloma.

Dr. Cesar Rodriguez has spent the last seven years dedicated to advancing the field of multiple myeloma — which he discussed in this week’s episode of the “CURE Talks Cancer” podcast.

Rodriguez highlighted advances with precision medicine in the multiple myeloma treatment landscapes, and common questions patients have for their physicians.

Moreover, he also highlighted his recent trek to Patagonia with Moving Mountains for Multiple Myeloma, an effort partnered by CURE and the Multiple Myeloma Research Foundation. Through the trek, Rodriguez was able to meet with patients and their caregivers about a disease he has spent his career dedicated to finding more treatments for.

For more information, visit movingmountainsformultiplemyeloma.com.

Related Videos
Dr. Mikhael in an interview with CURE
Dr. Ajai Chari in an in interview with CURE
An image of Dr. Patel in an interview with CURE discussing healthy lifestyles in myeloma
Dr. Munshi in an interview with CURE
Dr. Dikran Kazandjian during an interview with CURE
Related Content
Image of red blood cells.
November 18th 2024

Blenrep-Based Combo Provides Survival Benefit in Relapsed/Refractory Multiple Myeloma

Darlene Dobkowski, MA
Findings from a phase 3 trial with Blenrep, Velcade and dexamethasone in relapsed/refractory multiple myeloma will be presented at an upcoming conference.
cancer horizons logo: a white microphone on a navy blue background
March 11th 2024

Oncology Approvals, Psychological Outcomes for Survivors and an Ovarian Cancer Vaccine

Alex Biese Brielle Benyon
Last week we saw some FDA approvals come through, as well as research that explored the psychosocial outcomes of individuals who survived pediatric rhabdosarcoma.
Image of a myeloma cell with a magnifying glass over it.
November 11th 2024

FDA Receives Application Seeking Approval of Darzalex Faspro in Smoldering Myeloma

Darlene Dobkowski, MA
If approved by the FDA, Darzalex Faspro may be the first treatment for smoldering multiple myeloma as compared to treating the disease once it progresses.
cancer horizons podcast logo: a white microphone on a blue background
March 4th 2024

Cannabis Talks During Cancer, Cardiometabolic Comorbidities and Current Research

Alex Biese Brielle Benyon
In addition to a breakthrough therapy designation for a lung cancer drug, this week we’ll be talking a lot about additional side effects and health conditions that may come with a cancer diagnosis, and how to manage them.
Image of three icons related to multiple myeloma.
November 5th 2024

Carvykti Effective for R/R Multiple Myeloma in Real-World Setting

Alex Biese
The CAR-T cell therapy Carvykti has been shown to be effective among patients outside the confines of a clinical trial.
image of breast cancer cells.
October 25th 2024

Jenna Fischer Shares Breast Cancer Details, Los Angeles Dodgers Broadcaster in Remission and More

Alex Biese Ashley Chan
From “The Office” star opening up in a new interview to Charley Steiner revealing his multiple myeloma journey, here is this week’s cancer news.